Skip to main content
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
ilaria.zizzari@uniroma1.it
Ilaria Grazia Zizzari
Ricercatore
Struttura:
DIPARTIMENTO DI MEDICINA SPERIMENTALE
E-mail:
ilaria.zizzari@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Publications
Title
Published on
Year
CAR-T cell. the long and winding road to solid tumors
CELL DEATH & DISEASE
2018
Immunobiology of solid cancers: cellular and molecular pathways as potential diagnostic and therapeutic targets
BIOMED RESEARCH INTERNATIONAL
2018
Anisakis pegreffii impacts differentiation and function of human dendritic cells
PARASITE IMMUNOLOGY
2018
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway
CANCER IMMUNOLOGY RESEARCH
2018
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer. A meta-analysis
GYNECOLOGIC ONCOLOGY
2018
The microbiota impact. bacteria shaping immunity, disease and response to therapy
TRANSLATIONAL CANCER RESEARCH
2018
The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one
CANCER TREATMENT REVIEWS
2018
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
JOURNAL OF TRANSLATIONAL MEDICINE
2018
Tumor derived Microvesicles enhance cross-processing ability of clinical grade Dendritic Cells
FRONTIERS IN IMMUNOLOGY
2018
Specific human cholangiocarcinoma (CCA) subpopulations of cancer stem cells (CSCs) express DoubleCortin-Like Kinase 1 (DCLK1) and DCLK1 inhibition induces anti-cancer effects
Digestive and Liver Disease
2018
Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment
ONCOTARGET
2017
Tumor-derived microvesicles modulate antigen cross-processing via reactive oxygen species-mediated alkalinization of phagosomal compartment in dendritic cells
FRONTIERS IN IMMUNOLOGY
2017
The sexist behaviour of immune checkpoint inhibitors in cancer therapy?
ONCOTARGET
2017
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients
JOURNAL OF CLINICAL ONCOLOGY
2017
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial
INTERNATIONAL JOURNAL OF ONCOLOGY
2016
Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues
STEM CELL RESEARCH & THERAPY
2016
Immunological and clinical impact of cancer stem cells in vulvar cancer: role of CD133/CD24/ABCG2-Expressing Cells
ANTICANCER RESEARCH
2016
Interleukin-15 enhances cytokine induced killer (CIK) cytotoxic potential against epithelial cancer cell lines via an innate pathway
HUMAN IMMUNOLOGY
2016
The macrophage Galactose-type C-type Lectin (MGL) modulates regulatory T cell functions
PLOS ONE
2015
MGL receptor and immunity: when the ligand can make the difference
JOURNAL OF IMMUNOLOGY RESEARCH
2015
« first
< previous
1
2
3
ERC
LS6
LS6_2
LS6_3
LS6_11
LS7_2
Interessi di ricerca
Keywords
anticancer immunotherapy
anti-tumor immune response
biomarkers tumor
dendritic cells
Progetti di Ricerca
NETWORK MEDICINE IN IMMUNO-ONCOLOGY: INTEGRATING CLINICAL AND LABORATORY DATA TO GENERATE PRECISION ROADMAPS FOR CANCER PATIENTS
Impact of circulating immune molecules on clinical outcome of uveal melanoma patients
Prognostic and predictive role of microbioma in NSCLC patients treated with anti-PD1 therapy
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma